LGALS8 Antikörper (AA 20-317)
Kurzübersicht für LGALS8 Antikörper (AA 20-317) (ABIN7153465)
Target
Alle LGALS8 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 20-317
-
Kreuzreaktivität
- Human
-
Aufreinigung
- Antigen Affinity Purified
-
Immunogen
- Recombinant Human Galectin-8 protein (20-317AA)
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- Recommended dilution: IHC:1:20-1:200,
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
- PBS with 0.02 % sodium azide, 50 % glycerol, pH 7.3.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C,-80 °C
-
Informationen zur Lagerung
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
-
- LGALS8 (Lectin, Galactoside-Binding, Soluble, 8 (LGALS8))
-
Andere Bezeichnung
- LGALS8
-
Hintergrund
-
Background: Lectin with a marked preference for 3\\\'-O-sialylated and 3\\\'-O-sulfated glycans.
Aliases: Gal 8 antibody, Gal-8 antibody, Gal8 antibody, Galectin 8 antibody, Galectin-8 antibody, galectin-8g antibody, Lectin galactoside binding soluble 8 antibody, LEG8_HUMAN antibody, LGAL S8 antibody, Lgals8 antibody, PCTA 1 antibody, PCTA-1 antibody, PCTA1 antibody, Po66 carbohydrate binding protein antibody, Po66 carbohydrate-binding protein antibody, Po66 CBP antibody, Po66-CBP antibody, Prostate carcinoma tumor antigen 1 antibody
-
UniProt
- O00214
Target
-